Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
Zhuangzhuang Zhang(University of Kentucky), Xiaoqi Liu(University of Kentucky), Qi Qiao(University of Kentucky), Nadia A. Lanman(Purdue University West Lafayette), Derek B. Allison(University of Kentucky), Lijun Cheng(Taizhou Central Hospital), Nuha Shaker(University of Kentucky), Anju Karki(Purdue University West Lafayette), B. Mark Evers(Center for Cancer Research), Kunyu Li(University of Kentucky), Qing Shao(Western University), Xiongjian Rao(University of Kentucky), Daheng He(University of Kentucky), Sagar M. Utturkar(Purdue University West Lafayette), Chi Wang(Markey Cancer Center), Jie Li(Purdue University West Lafayette), Piotr Rychahou(University of Kentucky), Stephen F. Konieczny(Purdue University West Lafayette)
Cited by 68
Related Papers
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
|Cancer Research|2011|539
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
|BMC Genomics|2016|228
Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia
|American Journal Of Pathology|2007|210